Skip to main content
. 2019 Apr 2;11:291–300. doi: 10.1016/j.dadm.2019.02.002

Table 1.

Summary of the preanalytical variable assessments in this study

Parameter Factor Outcome
Circadian rhythm (Fig. 1A)
  • Time of day of blood collection: 8:00, 12:00, 15:00

  • Small diurnal variability observed for Aβ(1-40), Aβ(1-42), tTau; no effect for Aβ(1-42): Aβ(1-40) ratio

Anticoagulant (Fig. 1B) (EDTA used as reference)
  • Li-heparin

  • Increase of Aβ(1-40) and Aβ(1-42); decrease of tTau

  • Na-citrate

  • Decrease of Aβ(1-40), Aβ(1-42), tTau; increase for Aβ(1-42): Aβ(1-40) ratio

Tube parameters (Fig. 1C; Fig. 1D)
  • Material: PP, PET

  • No effect

  • Sample size (mL): 2.7, 4.9, 8.5, 9, 10

  • No effect

  • EDTA cation: K2, K3

  • No effect

  • Gel separator: +/-

  • No effect

  • Filling height: full, half-filling height

  • Decrease of tTau

Whole blood stability in EDTA tube (Fig. 2A)
  • Time to centrifugation (h): 0.5, 1, 2, 6, 24

  • Aβ(1-40) and Aβ(1-42) stable up to 1h

  • If Aβ(1-42): Aβ(1-40) ratio is reported, stable up to 2h

  • tTau stable up to 6h

EDTA plasma storage after thawing (Fig. 2B)
  • +4°C; time to measurement (h): 0, 1, 6, 24

  • Aβ(1-40) and Aβ(1-42) stable up to 6h at +4°C and 1h at RT

  • RT; time to measurement (h): 0, 1, 6, 24

  • Aβ(1-42): Aβ(1-40) ratio stable up to 24h (both +4°C and RT)

Fresh EDTA plasma storage (Fig. 2C)
  • +4°C; time to measurement (h): 0, 1, 3, 6, 24

  • Stable up to 6h

Number of tube transfers (Fig. 3A)
  • 1×, 2×, 3×, 4×, 5×

  • No effect

Effect of the collection tube on stability during freezing (Fig. 3B)
  • Material (PP, PET)

  • No effect

  • Sample size (mL): 2.7, 4.9, 8.5, 9, 10

  • No effect

  • EDTA cation (K2, K3)

  • No effect

  • Gel separator (+/-)

  • No effect

Freeze/thaw cycles (–80°C) (Fig. 3C)
  • 1×, 2×, 3×

  • No effect

Freeze/thaw cycles (–25°C) (Fig. 3D)
  • 1×, 2×, 3×

  • No effect

Freeze/thaw cycles (–20°C) (Fig. 3D)
  • 1×, 2×, 3×

  • No effect

Abbreviations: Aβ, amyloid β; EDTA, ethylenediaminetetraacetic acid; Li-heparin, lithium heparin; PET, polyethylene terephthalate; PP, polypropylene; RT, room temperature; tTau, total Tau.

Outcomes listed apply to all peptide measures unless otherwise indicated.

Only Aβ(1-40) and Aβ(1-42) and Aβ(1-42): Aβ(1-40) assessed; tTau not evaluated due to the high stability of tTau in thawed plasma.